Status:
COMPLETED
Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy
Lead Sponsor:
Spaulding Rehabilitation Hospital
Conditions:
Achilles Tendinopathy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This is a randomized control trial with an elective cross over after three months to evaluate three different treatments in the management of non-insertional Achilles Tendinopathy. The treatment metho...
Detailed Description
This is a randomized control study with an elective cross over. In part 1 of the study participants will be randomized into one of three treatment arms: 1) physical therapy only; 2) physical therapy a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- A diagnosis of mid-portion Achilles tendinopathy (including both unilateral and bilateral)
- Running is the pre-injury primary form of physical activity and pre-injury would complete on average 10 miles per week or more of running
- VISA-A \<80 at baseline to be eligible
- Exclusion Criteria
- Less than 3 months of symptoms
- Primary insertional Achilles tendinopathy
- Diagnosis of rheumatological disease/connective tissue condition, symptomatic arthritis of foot and ankle, a primary running related injury outside Achilles tendinopathy, other contraindications to PBMT or SWT
- Have received SWT within the past 3 months to their Achilles
- Prior injection within 3 months
- Currently enrolled in PT for more than 4 weeks for their condition
- Women who are pregnant.
- known history of Achilles tendon tear
- currently taking oral steroid or fluoroquinolone class of antibiotics
Exclusion
Key Trial Info
Start Date :
August 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04725513
Start Date
August 29 2022
End Date
October 1 2024
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spaulding Hospital Cambridge
Cambridge, Massachusetts, United States, 02138